Among 20,003 adults with elevated blood pressure or stage 1–2 hypertension who logged cuff readings through a consumer wearable platform, adjusted systolic pressure fell by 2.6 mmHg in the elevated group and 12.1 mmHg in stage 2 hypertension over six months. Overall, 50.2% achieved a systolic drop of at least 5 mmHg and 27.9% reached normal BP. App time, journaling, AI Coach use and frequent BP logging predicted reductions; longer sleep and more physical activity accompanied lower readings.
The gradient is the first thing to distrust. Larger drops in people starting with higher pressure are what regression to the mean predicts, and this cohort has no control group to separate that from any real effect. Users also chose to log readings, so the analysis captures motivated people who kept measuring, and those who disengaged or stopped logging vanish from the data. Medication changes are not described in the abstract, so a doctor adjusting prescriptions could explain much of the stage 2 improvement. The engagement associations run in both causal directions: people whose BP is improving may simply use the app more. Still, a 12 mmHg systolic fall, if real, matches what single antihypertensive drugs achieve and would meaningfully lower stroke and cardiovascular risk. This is a preprint awaiting peer review, so numbers and conclusions may shift. The practical takeaway is modest: home cuff monitoring plus sleep and activity tracking can support BP management alongside medical care, but this work is observational and confirmatory at best. Randomized evidence is needed before wearables are credited with the improvement.